Table 3.
Agents | MIC [μg/ml] | P-value | |||||
---|---|---|---|---|---|---|---|
Patients with AD | Control group | ||||||
Range | MIC 50 | MIC 90 | Range | MIC 50 | MIC 90 | ||
Ampicillin | 0.125–32 | 2 | 16 | 0.25–32 | 16 | 32 | 0.125584 |
Ciprofloxacin | 0.125–>512 | 0.5 | 2 | 0.125–1 | 0.25 | 1 | 0.2214 |
Daptomycin | 0.125–4 | 2 | 4 | 1–2 | 2 | 2 | 0.6965 |
Erythromycin | 0.125–>512 | 0.5 | > 512 | 0.125–>512 | 1 | > 512 | 0.7188 |
Fusidic acid | 0.312–32 | 0.125 | 8 | 0.125–16 | 1 | 16 | 0.0242 |
Linezolid | 0.25–32 | 1 | 4 | 1–4 | 2 | 4 | 0.125059 |
Lincomycin | 0.25–>512 | 1 | 64 | 0.25–>512 | 0.5 | > 512 | 0.25239 |
Mupirocin | 0.125–>512 | 0.5 | > 512 | 0.125–32 | 0.25 | 32 | 0.25257 |
Tetracycline | 0.125–64 | 0.5 | 32 | 0.125–32 | 0.5 | 32 | 0.8630 |
Vancomycin | 0.125–8 | 0.5 | 2 | 0.25–1 | 1 | 1 | 0.8069 |
MIC 50 – MIC for 50% of isolates. MIC 90 – MIC for 90% of isolates. Significant differences between groups determined with Mann-Whitney U test.